Lipopolysaccharide (LPS) stimulation of Pancreatic Ductal Adenocarcinoma (PDAC) and macrophages activates the NLRP3 inflammasome that influences the levels of pro-inflammatory cytokines in a co-culture model

References

• McGuigan A, Kelly P, Turkington RC, Jones C, Coleman HG, McCain RS. Pancreatic cancer: a review of clinical diagnosis, epidemiology, treatment and outcomes. World J Gastroenterol. 2018 Nov 21;24(43):4846–12. doi:10.3748/wjg.v24.i43.4846.
   PubMed Web of Science ®Google Scholar
• Laheru D. 2020. Pancreatic cancer. Goldman-Cecil Med 26th Ed: Chapter. 185:1305–1308.e1302.
   Google Scholar
• Wadsworth C. 2021. Biliary tract and pancreatic disease. Kumar And Clark’s Clin Med. 35:1313–1337.
   Google Scholar
• Guo JY, Chen H-Y, Mathew R, Fan J, Strohecker AM, Karsli-Uzunbas G, Kamphorst JJ, Chen G, Lemons JMS, Karantza V, et al. Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev. 2011;25(5):460–470. doi:10.1101/gad.2016311.
   PubMed Web of Science ®Google Scholar
• Ling J, Kang Y, Zhao R, Xia Q, Lee D-F, Chang Z, Li J, Peng B, Fleming J, Wang H, et al. KrasG12D-induced IKK2/β/NF-κB activation by IL-1α and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma. Cancer Cell. 2012;21(1):105–120. doi:10.1016/j.ccr.2011.12.006.
   PubMed Web of Science ®Google Scholar
• Yang S, Wang X, Contino G, Liesa M, Sahin E, Ying H, Bause A, Li Y, Stommel JM, Dell’Antonio G, et al. Pancreatic cancers require autophagy for tumor growth. Genes Dev. 2011;25(7):717–729. doi:10.1101/gad.2016111.
   PubMed Web of Science ®Google Scholar
• Kopp JL, von Figura G, Mayes E, Liu F-F, Dubois C, Morris J, Pan F, Akiyama H, Wright CE, Jensen K, et al. Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma. Cancer Cell. 2012;22(6):737–750. doi:10.1016/j.ccr.2012.10.025.
   PubMed Web of Science ®Google Scholar
• Chen C, Edelstein LC, Gélinas C. The Rel/NF-κB family directly activates expression of the apoptosis inhibitor Bcl-x L. Mol Cell Biol. 2000;20(8):2687–2695. doi:10.1128/MCB.20.8.2687-2695.2000.
   PubMed Web of Science ®Google Scholar
• Erkan M, Hausmann S, Michalski CW, Fingerle AA, Dobritz M, Kleeff J, Friess H. The role of stroma in pancreatic cancer: diagnostic and therapeutic implications. Nat Rev Gastroenterol Hepatol. 2012;9(8):454–467. doi:10.1038/nrgastro.2012.115.
   PubMed Web of Science ®Google Scholar
• Liptay S, Weber CK, Ludwig L, Wagner M, Adler G, Schmid RM. Mitogenic and antiapoptotic role of constitutive NF-κB/Rel activity in pancreatic cancer. Int J Cancer. 2003;105(6):735–746. doi:10.1002/ijc.11081.
   PubMed Web of Science ®Google Scholar
• Liu T, Zhang L, Joo D, Sun S-C. NF-κB signaling in inflammation. Sig Transduct Target Ther. 2017;2(1):17023. doi:10.1038/sigtrans.2017.23.
   PubMed Web of Science ®Google Scholar
• Romashkova JA, Makarov SS. NF-κB is a target of AKT in anti-apoptotic PDGF signalling. Nature. 1999;401(6748):86–90. doi:10.1038/43474.
   PubMed Web of Science ®Google Scholar
• Guerra C, Collado M, Navas C, Schuhmacher A, Hernández-Porras I, Cañamero M, Rodriguez-Justo M, Serrano M, Barbacid M. Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence. Cancer Cell. 2011;19(6):728–739. doi:10.1016/j.ccr.2011.05.011.
   PubMed Web of Science ®Google Scholar
• Hu H, Jiao F, Han T, Wang L-W. Functional significance of macrophages in pancreatic cancer biology. Tumor Biol. 2015;36(12):9119–9126. doi:10.1007/s13277-015-4127-2.
   PubMedGoogle Scholar
• Galdiero MR, Biswas SK, Mantovani A. Polarized activation of macrophages. In: Biswas SK, and Mantovani A, editors Macrophages: biology and role in the pathology of diseases. New York, NY: Springer New York; 2014. pp. 37–57.
   Google Scholar
• Sica A, Straus L, Allavena P. Tumor-associated macrophages. In: Biswas SK, and Mantovani A, editors Macrophages: biology and role in the pathology of diseases. New York, NY: Springer New York; 2014. pp. 425–443.
   Google Scholar
• Wang X, Luo G, Zhang K, Cao J, Huang C, Jiang T, Liu B, Su L, Qiu Z. Hypoxic Tumor-Derived Exosomal miR-301a Mediates M2 Macrophage Polarization via PTEN/PI3Kγ to Promote Pancreatic Cancer Metastasis. Cancer Res. 2018;78(16):4586–4598. doi:10.1158/0008-5472.CAN-17-3841.
   PubMed Web of Science ®Google Scholar
• Xiong C, Zhu Y, Xue M, Jiang Y, Zhong Y, Jiang L, Shi M, Chen H. Tumor-associated macrophages promote pancreatic ductal adenocarcinoma progression by inducing epithelial-to-mesenchymal transition. Aging. 2021;13(3):3386–3404. doi:10.18632/aging.202264.
   PubMedGoogle Scholar
• Sharma BR, Kanneganti T-D. NLRP3 inflammasome in cancer and metabolic diseases. Nat Immunol. 2021;22(5):550–559. doi:10.1038/s41590-021-00886-5.
   PubMed Web of Science ®Google Scholar
• Daley D, Mani VR, Mohan N, Akkad N, Pandian GSDB, Savadkar S, Lee KB, Torres-Hernandez A, Aykut B, Diskin B, et al. NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma. J Exp Med. 2017;214(6):1711–1724. doi:10.1084/jem.20161707.
   PubMed Web of Science ®Google Scholar
• Groslambert M, Py B. Spotlight on the NLRP3 inflammasome pathway. JIR. 2018;11:359–374. doi:10.2147/JIR.S141220.
   Google Scholar
• Kelley N, Jeltema D, Duan Y, He Y. The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. Int J Mol Sci. 2019;20(13):3328. doi:10.3390/ijms20133328.
   PubMed Web of Science ®Google Scholar
• Swanson KV, Deng M, Ting JPY. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. 2019;19(8):477–489. doi:10.1038/s41577-019-0165-0.
   PubMed Web of Science ®Google Scholar
• Baker KJ, Houston A, Brint E. IL-1 family members in cancer; two sides to every story. Front Immunol. 2019;10:1197–1197. doi:10.3389/fimmu.2019.01197.
   PubMed Web of Science ®Google Scholar
• Sun Y, Guo Y. Expression of caspase-1 in breast cancer tissues and its effects on cell proliferation, apoptosis and invasion. Oncol Lett. 2018;15(5):6431–6435. doi:10.3892/ol.2018.8176.
   PubMed Web of Science ®Google Scholar
• Thi HTH, Hong S. Inflammasome as a therapeutic target for cancer prevention and treatment. J Cancer Prev. 2017;22(2):62–73. doi:10.15430/JCP.2017.22.2.62.
   PubMed Web of Science ®Google Scholar
• Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer. 2012;12(4):252–264. doi:10.1038/nrc3239.
   PubMed Web of Science ®Google Scholar
• Greten FR, Weber CK, Greten TF, Schneider G, Wagner M, Adler G, Schmid RM. Stat3 and NF-κB activation prevents apoptosis in pancreatic carcinogenesis. Gastroenterology. 2002;123(6):2052–2063. doi:10.1053/gast.2002.37075.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Rigas B. NF-κB, inflammation and pancreatic carcinogenesis: NF-κB as a chemoprevention target (Review). Int J Oncol. 2006;29(1):185–192. doi:10.3892/ijo.29.1.185.
   PubMed Web of Science ®Google Scholar
• Gaiser RA, Halimi A, Alkharaan H, Lu L, Davanian H, Healy K, Hugerth LW, Ateeb Z, Valente R, Fernández Moro C, et al. Enrichment of oral microbiota in early cystic precursors to invasive pancreatic cancer. Gut. 2019;68(12):2186–2194. doi:10.1136/gutjnl-2018-317458.
   PubMed Web of Science ®Google Scholar
• Das S, Shapiro B, Vucic EA, Vogt S, Bar-Sagi D. Tumor cell–derived IL1β promotes desmoplasia and immune Suppression in pancreatic cancer. Cancer Res. 2020;80(5):1088–1101. doi:10.1158/0008-5472.CAN-19-2080.
   PubMed Web of Science ®Google Scholar
• Flint TR, Janowitz T, Connell C, Roberts E, Denton A, Coll A, Jodrell D, Fearon D. Tumor-induced IL-6 reprograms Host metabolism to suppress anti-tumor immunity. Cell Metab. 2016;24(5):672–684. doi:10.1016/j.cmet.2016.10.010.
   PubMed Web of Science ®Google Scholar
• Wang X, Lin Y. Tumor necrosis factor and cancer, buddies or foes? Acta Pharmacol Sin. 2008;29(11):1275–1288. doi:10.1111/j.1745-7254.2008.00889.x.
   PubMed Web of Science ®Google Scholar
• Zelová H, Hošek J. TNF-α signalling and inflammation: interactions between old acquaintances. Inflamm Res. 2013;62(7):641–651. doi:10.1007/s00011-013-0633-0.
   PubMed Web of Science ®Google Scholar
• Balkwill F. TNF-α in promotion and progression of cancer. Cancer Metastasis Rev. 2006;25(3):409–416. doi:10.1007/s10555-006-9005-3.
   PubMed Web of Science ®Google Scholar
• Sethi G, Shanmugam M, Ramachandran L, Kumar A, Tergaonkar V. Multifaceted link between cancer and inflammation. Biosci Rep. 2011;32(1):1–15. doi:10.1042/BSR20100136.
   Web of Science ®Google Scholar
• McGeough MD, Wree A, Inzaugarat ME, Haimovich A, Johnson CD, Peña CA, Goldbach-Mansky R, Broderick L, Feldstein AE, Hoffman HM. TNF regulates transcription of NLRP3 inflammasome components and inflammatory molecules in cryopyrinopathies. J Clin Invest. 2017;127(12):4488–4497. doi:10.1172/JCI90699.
   PubMed Web of Science ®Google Scholar
• Neta R, Sayers TJ, Oppenheim JJ. 1992. Relationship of TNF to interleukins. Immunol Ser. 56:499–566.
   PubMedGoogle Scholar
• Wu D, Chen Y, Sun Y, Gao Q, Li H, Yang Z, Wang Y, Jiang X, Yu B. Target of MCC950 in inhibition of NLRP3 inflammasome activation: a literature review. Inflammation. 2020;43(1):17–23. doi:10.1007/s10753-019-01098-8.
   PubMed Web of Science ®Google Scholar
• Chen S-P, Zhou Y-Q, Wang X-M, Sun J, Cao F, HaiSam S, Ye D-W, Tian Y-K. Pharmacological inhibition of the NLRP3 inflammasome as a potential target for cancer-induced bone pain. Pharmacol Res. 2019;147:104339. doi:10.1016/j.phrs.2019.104339.
   PubMed Web of Science ®Google Scholar
• Huang C-F, Chen L, Li Y-C, Wu L, Yu G-T, Zhang W-F, Sun Z-J. NLRP3 inflammasome activation promotes inflammation-induced carcinogenesis in head and neck squamous cell carcinoma. J Exp Clin Cancer Res. 2017;36(1):116. doi:10.1186/s13046-017-0589-y.
   PubMedGoogle Scholar
• Shi J, Xue J. Inflammation and development of pancreatic ductal adenocarcinoma. Chin Clin Oncol. 2019;8(2):19–19. doi:10.21037/cco.2019.04.02.
   PubMed Web of Science ®Google Scholar
• Kong X, Sun T, Kong F, Du Y, Li Z. Chronic pancreatitis and pancreatic cancer. Gastrointest Tumors. 2014;1(3):123–134. doi:10.1159/000365306.
   PubMedGoogle Scholar
• Hausmann S, Kong, B., Michalski, C., Erkan, M. and Friess, H. The role of inflammation in pancreatic cancer. In: Aggarwal BB, Sung B Gupta SC, editors Inflammation and cancer. Basel: Springer Basel; 2014. pp. 129–151.
   Google Scholar
• Kolodecik T, Shugrue C, Ashat M, Thrower EC. Risk factors for pancreatic cancer: underlying mechanisms and potential targets. Front Physiol. 2014;4:415–415. doi:10.3389/fphys.2013.00415.
   PubMed Web of Science ®Google Scholar
• Yaw ACK, Chan EWL, Yap JKY, Mai CW. The effects of NLRP3 inflammasome inhibition by MCC950 on LPS-induced pancreatic adenocarcinoma inflammation. J Cancer Res Clin Oncol. 2020;146(9):2219–2229. doi:10.1007/s00432-020-03274-y.
   PubMed Web of Science ®Google Scholar
• Chantôme A, Pance A, Gauthier N, Vandroux D, Chenu J, Solary E, Jeannin J-F, Reveneau S. Casein Kinase II-mediated phosphorylation of NF-κB p65 Subunit enhances Inducible Nitric-oxide synthase gene transcription in Vivo*. J Biol Chem. 2004;279(23):23953–23960. doi:10.1074/jbc.M313731200.
   PubMed Web of Science ®Google Scholar
• Cornut M, Bourdonnay E, Henry T. Transcriptional regulation of inflammasomes. Int J Mol Sci. 2020;21(21):8087. doi:10.3390/ijms21218087.
   PubMed Web of Science ®Google Scholar
• Engström A, Erlandsson A, Delbro D, Wijkander J. Conditioned media from macrophages of M1, but not M2 phenotype, inhibit the proliferation of the colon cancer cell lines HT-29 and CACO-2. Int J Oncol. 2014;44(2):385–392. doi:10.3892/ijo.2013.2203.
   PubMed Web of Science ®Google Scholar
• Tao M, Liu L, Shen M, Zhi Q, Gong F-R, Zhou BP, Wu Y, Liu H, Chen K, Shen B, et al. Inflammatory stimuli promote growth and invasion of pancreatic cancer cells through NF-κB pathway dependent repression of PP2Ac. Cell Cycle (Georgetown, Tex). 2016;15(3):381–393. doi:10.1080/15384101.2015.1127468.
   PubMed Web of Science ®Google Scholar
• Corcoran RB, Contino G, Deshpande V, Tzatsos A, Conrad C, Benes CH, Levy DE, Settleman J, Engelman JA, Bardeesy N. STAT3 plays a Critical role in KRAS-induced pancreatic Tumorigenesis. Cancer Res. 2011;71(14):5020–5029. doi:10.1158/0008-5472.CAN-11-0908.
   PubMed Web of Science ®Google Scholar
• Mollinedo F, Gajate C. Novel therapeutic approaches for pancreatic cancer by combined targeting of RAF→MEK→ERK signaling and autophagy survival response. Ann Transl Med. 2019;7(Suppl S3):S153–S153. doi:10.21037/atm.2019.06.40.
   PubMedGoogle Scholar
• Storz P. Targeting protein kinase C subtypes in pancreatic cancer. Expert Rev Anticancer Ther. 2015;15(4):433–438. doi:10.1586/14737140.2015.1003810.
   PubMed Web of Science ®Google Scholar
• Takahashi R, Hirata Y, Sakitani K, Nakata W, Kinoshita H, Hayakawa Y, Nakagawa H, Sakamoto K, Hikiba Y, Ijichi H, et al. Therapeutic effect of c-Jun N-terminal kinase inhibition on pancreatic cancer. Cancer Sci. 2013;104(3):337–344. doi:10.1111/cas.12080.
   PubMed Web of Science ®Google Scholar
• Coll RC, Hill JR, Day CJ, Zamoshnikova A, Boucher D, Massey NL, Chitty JL, Fraser JA, Jennings MP, Robertson AAB, et al. MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition. Nat Chem Biol. 2019;15(6):556–559. doi:10.1038/s41589-019-0277-7.
   PubMed Web of Science ®Google Scholar
• He Y, Hara H, Núñez G. Mechanism and regulation of NLRP3 inflammasome activation. Trends Biochem Sci. 2016;41(12):1012–1021. doi:10.1016/j.tibs.2016.09.002.
   PubMed Web of Science ®Google Scholar
• Song H, Liu B, Huai W, Yu Z, Wang W, Zhao J, Han L, Jiang G, Zhang L, Gao C, et al. The E3 ubiquitin ligase TRIM31 attenuates NLRP3 inflammasome activation by promoting proteasomal degradation of NLRP3. Nat Commun. 2016;7(1):13727. doi:10.1038/ncomms13727.
   PubMedGoogle Scholar
• Zhu L, Meng Q, Liang S, Ma Y, Li R, Li G, Zeng H. The transcription factor GFI1 negatively regulates NLRP3 inflammasome activation in macrophages. FEBS Lett. 2014;588(23):4513–4519. doi:10.1016/j.febslet.2014.10.025.
   PubMed Web of Science ®Google Scholar
• Wang B, Wei H, Prabhu L, Zhao W, Martin M, Hartley A-V, Lu T. Role of Novel Serine 316 phosphorylation of the p65 subunit of NF-κB in differential gene regulation. J Biol Chem. 2015;290(33):20336–20347. doi:10.1074/jbc.M115.639849.
   PubMed Web of Science ®Google Scholar